Hiroki Ishiguro

6.4k citations

92 papers · 4.5k indexed · 1 hit paper · h-index 36

Cellular and Molecular Neuroscience top 0.5%
Pharmacology top 0.1%
Molecular Biology top 10%
Cognitive Neuroscience top 2%
Genetics top 5%

Co-authors: Tadao Arinami Emmanuel S. Onaivi George R. Uhl Qing‐Rong Liu Patricia Tagliaferro Alicia Brusco Jian-Ping Gong Michio Toru
Topics: Neurotransmitter Receptor Influence on Behavior (33 papers)Cannabis and Cannabinoid Research (30 papers)Neuroscience and Neuropharmacology Research (18 papers)
Cited by: Pharmacology Cellular and Molecular Neuroscience Biological Psychiatry
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Neurology
Partner nations: Japan United States Argentina

In The Last Decade

Hiroki Ishiguro

90 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

2006 629 citations Emmanuel S. Onaivi, Hiroki Ishiguro et al. profile →

Peers

Countries citing papers authored by Hiroki Ishiguro

Since Specialization

Citations

This map shows the geographic impact of Hiroki Ishiguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Ishiguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Ishiguro more than expected).

Fields of papers citing papers by Hiroki Ishiguro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Ishiguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Ishiguro. The network helps show where Hiroki Ishiguro may publish in the future.

Co-authorship network of co-authors of Hiroki Ishiguro

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Ishiguro. A scholar is included among the top collaborators of Hiroki Ishiguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Ishiguro. Hiroki Ishiguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A parent-rating scale of postpartum depression: Maternity-monitoring scale by parents (MMSP) 2024 ·Journal of Psychiatric Research ·Yoshiaki Ohashi,(unknown),K. Hanawa,Hiroshi Yokomichi,Hiroki Ishiguro	0
2	Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia 2023 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Ana Canseco-Alba,(unknown),(unknown),(unknown),Yasue Horiuchi,Tadao Arinami,Emmanuel S. Onaivi,Hiroki Ishiguro	0
3	Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference 2017 ·Scientific Reports ·Qing‐Rong Liu,Ana Canseco-Alba,Hai‐Ying Zhang,Patricia Tagliaferro,(unknown),(unknown),(unknown),Norman Schanz,(unknown),Hiroki Ishiguro,Zhicheng Lin,(unknown),Claire M. Leonard,Jair Guilherme Santos-Junior,Eliot L. Gardner,Josephine M. Egan,(unknown),Zheng‐Xiong Xi,Emmanuel S. Onaivi	122
4	Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: A three-stage case–control association study 2010 ·Schizophrenia Research ·(unknown),Yuichiro Watanabe,Naoshi Kaneko,Ayako Nunokawa,Tatsuyuki Muratake,Hiroki Ishiguro,Tadao Arinami,Hiroshi Ujike,Toshiya Inada,Nakao Iwata,Hiroshi Kunugi,Takehiko Sasaki,Ryota Hashimoto,Masanari Itokawa,Norio Ozaki,Toshiyuki Someya	5
5	Species differences in cannabinoid receptor 2 (CNR2) gene: identification of novel human and rodent CB2 isoforms, differential tissue expression, and regulation by cannabinoid receptor ligands 2009 ·Genes Brain & Behavior ·Qing‐Rong Liu,Chun‐Hung Pan,Akitoyo Hishimoto,Chuan‐Yun Li,Zheng‐Xiong Xi,Alvaro Llorente‐Berzal,María‐Paz Viveros,Hiroki Ishiguro,Tadao Arinami,Emmanuel S. Onaivi,George R. Uhl	17
6	Functional coupling of apical Cl⁻/HCO₃⁻ exchange with CFTR in stimulated HCO₃⁻ secretion by guinea pig interlobular pancreatic duct 2009 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Andrew K. Stewart,Akiko Yamamoto,(unknown),Takaharu Kondo,Seth L. Alper,Hiroki Ishiguro	50
7	Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects 2008 ·PLoS ONE ·Emmanuel S. Onaivi,Hiroki Ishiguro,Jian Ping Gong,(unknown),(unknown),Lester H. Myers,Alex Perchuk,(unknown),Patricia Tagliaferro,(unknown),Alicia Brusco,B. Emmanuel Akinshola,Bruce T. Hope,(unknown),Toshiya Inada,Shinya Iwasaki,David Macharia,(unknown),Tadao Arinami,George R. Uhl	213
8	Association of PTPRB gene polymorphism with drug addiction 2008 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Hiroki Ishiguro,Jianping Gong,F. Scott Hall,Tadao Arinami,George R. Uhl	14
9	Failure to confirm the association between the FEZ1 gene and schizophrenia in a Japanese population 2007 ·Neuroscience Letters ·Minori Koga,Hiroki Ishiguro,Yasue Horiuchi,(unknown),Toshiya Inada,Nakao Iwata,Norio Ozaki,Hiroshi Ujike,Tatsuyuki Muratake,Toshiyuki Someya,Tadao Arinami	16
10	Replication study and meta‐analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case‐control population 2007 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·(unknown),Yasue Horiuchi,Hiroki Ishiguro,Minori Koga,Toshiya Inada,Nakao Iwata,Norio Ozaki,Hiroshi Ujike,Yuichiro Watanabe,Toshiyuki Someya,Tadao Arinami	16
11	Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population 2007 ·Psychiatric Genetics ·Shinya Iwasaki,Hiroki Ishiguro,Susumu Higuchi,Emmanuel S. Onaivi,Tadao Arinami	27
12	Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver 2006 ·Life Sciences ·Hiroki Ishiguro,Yoshiaki Katano,Isao Nakano,Masatoshi Ishigami,Kazuhiko Hayashi,Takashi Honda,Hidemi Goto,Gustavo Bajotto,Ken Maeda,Yoshiharu Shimomura	24
13	Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse 2004 ·Molecular Psychiatry ·(unknown),Hiroki Ishiguro,Taisuke Ohtsuki,J Hess,(unknown),Donna Walther,Emmanuel S. Onaivi,Tadao Arinami,George R. Uhl	193
14	Ethanol induces fluid hypersecretion from guinea-pig pancreatic duct cells 2003 ·The Journal of Physiology ·Akiko Yamamoto,Hiroki Ishiguro,(unknown),Atsushi Suzuki,Yao Wang,Hiroyuki Hamada,Nobumasa Mizuno,Motoji Kitagawa,T Hayakawa,Satoru Naruse	31
15	Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders 2003 ·Biological Psychiatry ·Yasue Horiuchi,Junko Nakayama,Hiroki Ishiguro,Tsuyuka Ohtsuki,Sevilla D. Detera‐Wadleigh,Tomoko Toyota,Kazuo Yamada,Masahiro Nankai,Haruo Shibuya,Takeo Yoshikawa,Tadao Arinami	39
16	WFS1 gene mutation search in depressive patients: detection of five missense polymorphisms but no association with depression or bipolar affective disorder 2000 ·Journal of Affective Disorders ·Taisuke Ohtsuki,Hiroki Ishiguro,Takeo Yoshikawa,Tadao Arinami	35
17	Mutation and association analysis of the 5′ region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia 2000 ·Molecular Psychiatry ·Hiroki Ishiguro,Yuki Okuyama,Michio Toru,Tadao Arinami	37
18	The 5′ region of the tryptophan hydroxylase gene: mutation search and association study with alcoholism 1999 ·Journal of Neural Transmission ·Hiroki Ishiguro,Toshikazu Saito,H. Shibuya,Michio Toru,Tadao Arinami	21
19	Supportive evidence for contribution of the dopamine D2 receptor gene to heritability of stature: linkage and association studies 1999 ·Annals of Human Genetics ·Tadao Arinami,(unknown),Kimiko Yamakawa‐Kobayashi,Hiroki Ishiguro,Taisuke Ohtsuki,Hisako Yanagi,(unknown),Hiroki Ishikawa,Hideo Hamaguchi	19
20	An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population 1997 ·Psychiatry and Clinical Neurosciences ·Hiroki Ishiguro,Tadao Arinami,Kazuo Yamada,(unknown),Michio Toru,(unknown)	43

About Hiroki Ishiguro

Hiroki Ishiguro is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Pharmacology, having authored 92 papers that have together received 4.5k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (33 papers), Cannabis and Cannabinoid Research (30 papers) and Neuroscience and Neuropharmacology Research (18 papers). The work is most often cited by research in Pharmacology (2.4k citations), Cellular and Molecular Neuroscience (2.5k citations) and Biological Psychiatry (260 citations). Hiroki Ishiguro has collaborated with scholars based in Japan, United States and Argentina. Frequent co-authors include Tadao Arinami, Emmanuel S. Onaivi, George R. Uhl, Qing‐Rong Liu, Patricia Tagliaferro, Alicia Brusco, Jian-Ping Gong, Michio Toru, Yasue Horiuchi and Yuki Okuyama. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact